These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes. Chouinard G; Chouinard VA Psychother Psychosom; 2008; 77(2):69-77. PubMed ID: 18230939 [No Abstract] [Full Text] [Related]
23. Case study: neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatment. Connor DF; Benjamin S; Ozbayrak KR J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1490-4. PubMed ID: 8543517 [TBL] [Abstract][Full Text] [Related]
24. Drugs for psychiatric disorders. Med Lett Drugs Ther; 1994 Oct; 36(933):89-96. PubMed ID: 7935156 [No Abstract] [Full Text] [Related]
25. Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Viguera AC; Baldessarini RJ; Hegarty JD; van Kammen DP; Tohen M Arch Gen Psychiatry; 1997 Jan; 54(1):49-55. PubMed ID: 9006400 [TBL] [Abstract][Full Text] [Related]
26. A Case Report of Clonazepam Dependence: Utilization of Therapeutic Drug Monitoring During Withdrawal Period. Kacirova I; Grundmann M; Silhan P; Brozmanova H Medicine (Baltimore); 2016 Mar; 95(9):e2881. PubMed ID: 26945373 [TBL] [Abstract][Full Text] [Related]
27. Intermittent neuroleptic therapy and tardive dyskinesia: a literature review. Goldman MB; Luchins DJ Hosp Community Psychiatry; 1984 Dec; 35(12):1215-9. PubMed ID: 6150891 [TBL] [Abstract][Full Text] [Related]
28. Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam. Gouliaev G; Licht RW; Vestergaard P; Merinder L; Lund H; Bjerre L Acta Psychiatr Scand; 1996 Feb; 93(2):119-24. PubMed ID: 8686481 [TBL] [Abstract][Full Text] [Related]
30. A study of the need for anticholinergic medication in patients treated with long-term antipsychotics. Caradoc-Davies G; Menkes DB; Clarkson HO; Mullen PE Aust N Z J Psychiatry; 1986 Jun; 20(2):225-32. PubMed ID: 2876700 [TBL] [Abstract][Full Text] [Related]
34. Clonazepam withdrawal in 13 patients with active epilepsy and drug side effects. Buchanan N; Sharpe C Seizure; 1994 Dec; 3(4):271-5. PubMed ID: 7894837 [TBL] [Abstract][Full Text] [Related]
35. Quetiapine and neuroleptic malignant syndrome. Solomons K Can J Psychiatry; 2002 Oct; 47(8):791. PubMed ID: 12420666 [No Abstract] [Full Text] [Related]
36. Long-term studies on anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. I. Comparison of diazepam, clonazepam, clobazam and abecarnil. Löscher W; Rundfeldt C; Hönack D; Ebert U J Pharmacol Exp Ther; 1996 Nov; 279(2):561-72. PubMed ID: 8930158 [TBL] [Abstract][Full Text] [Related]
37. [Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal]. Ben Hadj Ali B; Dogui M; Ben Ammou S; Lôo H Encephale; 1995; 21(3):209-15. PubMed ID: 7649071 [TBL] [Abstract][Full Text] [Related]
38. Occurrence of seizures related to psychotropic medication among psychiatric inpatients. Popli AP; Kando JC; Pillay SS; Tohen M; Cole JO Psychiatr Serv; 1995 May; 46(5):486-8. PubMed ID: 7627674 [TBL] [Abstract][Full Text] [Related]
39. Clonazepam as a therapeutic adjunct to improve the management of psychiatric disorders. Morishita S; Aoki S; Watanabe S Psychiatry Clin Neurosci; 1998 Feb; 52(1):75-8. PubMed ID: 9682937 [TBL] [Abstract][Full Text] [Related]
40. Tapering clonazepam in patients with panic disorder after at least 3 years of treatment. Nardi AE; Freire RC; Valença AM; Amrein R; de Cerqueira AC; Lopes FL; Nascimento I; Mezzasalma MA; Veras AB; Sardinha A; de Carvalho MR; da Costa RT; Levitan MN; de-Melo-Neto VL; Soares-Filho GL; Versiani M J Clin Psychopharmacol; 2010 Jun; 30(3):290-3. PubMed ID: 20473065 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]